Breaking News, Collaborations & Alliances

NextWave, Tris Enter CNS Pact

NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave's CNS product portfolio.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave’s CNS product portfolio. Tris has reacquired the rights to non-CNS products including the OTC products previously licensed to NextWave. NextWave will commercialize NexiclonXR (clonidine) Extended-Release Tablets and Suspension, which is approved by the FDA and will be introduced to wholesalers ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters